RDHL
RedHill Biopharma Ltd. · Healthcare
0.83
3.72%(+0.03)
Prev. Close0.86
3.71%(+0.03)
Pre-marketLast Updated: — ET
52W L: $0.7152W H: $3.31
$0.86
CHG-0.06 (-6.54%)
H$0.95
L$0.51
VOL526K
RDHL (1h)
RedHill Biopharma Ltd. · Healthcare
Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF - Get Free Report) and Redhill Biopharma (NASDAQ: RDHL - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Earnings and Valuation This table
Redhill Biopharma Ltd. (NASDAQ: RDHL - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $1.27 and traded as low as $0.87. Redhill Biopharma shares last traded at $0.8899, with a volume of 7,208 shares traded. Analyst Upgrades and Downgrades Separately,
The full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc. (THI), a jointly controlled entity of RedHill and Cumberland has started and is now being rolled out to support accelerated market penetration and expanded reach Focused on unlocking the full market potential of Talicia, the #1 branded U.S. gastroenterologist-prescribed H. pylori therapy 1 , THI and Cumberland will manage the launch and ongoing joint commercialization activities H.
Redhill Biopharma Ltd. (NASDAQ: RDHL - Get Free Report) shares crossed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $1.39 and traded as low as $1.04. Redhill Biopharma shares last traded at $1.06, with a volume of 60,111 shares. Wall Street Analyst
Tsimchi Ofer
director
0 SH @ $0.00
2026-03-18
Tsimchi Ofer
director
36,440,000 SH @ $0.00
2026-03-18
Tsimchi Ofer
director
180,000 SH @ $0.00
2026-03-18
Scruggs Rick D
director, officer: Chief Commercial Officer
0 SH @ $0.00
2026-03-18
Scruggs Rick D
director, officer: Chief Commercial Officer
73,640,000 SH @ $0.00
2026-03-18
Scruggs Rick D
director, officer: Chief Commercial Officer
840,000 SH @ $0.00
2026-03-18
Reed Kenneth
director
0 SH @ $0.00
2026-03-18
Reed Kenneth
director
25,830,000 SH @ $0.00
2026-03-18